ClinicalTrials.govpublic full text
Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy
diabetic nephropathy, surrogate marker,, circulating soluble tnf receptor,, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 980447
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.